Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HylaPharm aims to tackle canine cancer with first-of-its-kind chemotherapy

The Bioscience and Biotechnology Center (BTBC) in the Kansas City Animal Health Corridor has played host to a number of successful start-ups. Now, one firm currently based at the BTBC is looking to target a number of cancers in pets with what it believes is a novel chemotherapy. Animal Pharm analyst Sian Lazell spoke to HylaPharm to find out more.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP010976

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel